Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
Oslo, 9 July 2024: Reference is made to the stock exchange announcement published by Circio Holding ASA (the "Company") on 8 July 2024 regarding the preliminary results of the rights issue of between 3,658,000 new shares to 20,732,010 new shares in the Company, at a subscription price of NOK 2.50 per share (the "Offer Shares") to raise gross proceeds of up to approximately NOK 52 million (the "Rights Issue").
The final allocation of the Offer Shares in the Rights Issue has now been completed by the Company's board of directors in accordance with the allocation criteria stated in the resolution made by the general meeting on 19 June 2024 and as set out in the Company's securities note approved on 18 June 2024 (the "Securities Note" and together with a registration document supplement and summary, approved on 18 June 2024, and a registration document approved on 28 September 2023 and a registration document supplement approved on 8 March 2024 comprises the "Prospectus").
A total of 7,242,992 Offer Shares were allocated, thereby raising gross proceeds of NOK 18,107,480 from the Rights Issue. In addition, the subscribers in the Rights Issue will be allocated one warrant for every Offer Share allocated and paid by them in the Rights Issue (the "Warrants") without additional consideration.
Further, a total of 621,860 shares and a corresponding number in Warrants without additional consideration, will be delivered to pre-subscribers pursuant to the pre-commitment and pre-subscription agreements entered into on or about 28 May 2024 as settlement of their entitlement to commission under that agreement. The shares will be issued pursuant to the resolution by the general meeting on 19 June 2024.
Notifications of allocated Offer Shares and the corresponding subscription amount to be paid by each subscriber are expected to be distributed today, on 9 July 2024. Payment for the allocated Offer Shares falls due on 10 July 2024 in accordance with the payment procedures described in the Prospectus.
The Offer Shares may not be transferred or traded before they have been fully paid and the share capital increase pertaining to the Rights Issue has been registered with the Norwegian Register of Business Enterprises (Nw.: Foretaksregisteret). It is expected that the share capital increase will be registered in the Norwegian Register of Business Enterprises on or about 19 July 2024 and that the Offer Shares will be delivered to the VPS accounts of the subscribers to whom they are allocated on or about the next business day.
The Offer Shares are expected to be tradable on Oslo Børs from and including 19 July 2024.
Redeye AB is acting as manager in the Rights Issue (the "Manager") and Advokatfirmaet Thommessen AS is acting as legal counsel to the Company in connection with the Rights Issue.
This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This stock exchange announcement was published by Mats Hermansen, VP Finance at Circio Holding ASA, at the date and time as set out above.